Contact Us - QuickVue At-Home

Contact Us

Logo for QuickVue At-Home OTC COVID-19 Test

Have Questions? We Can Help.

For product-related questions, please visit our FAQs to see if our knowledge base has your answers.

Still have questions? Complete the information below and someone from Quidel will contact you.

VIEW OUR FAQS

Still have questions? Complete the information below and someone from Quidel will contact you.

    * Required Fields

    Please find on back of package. See image for example.

    Lot number is located below the barcode on the back of product package.

    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    QuickVue At-Home OTC COVID-19 Test in box Product Questions?

    The QuickVue At-Home OTC COVID-19 Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 14 years or older with symptoms of COVID-19 within the first six days of symptom onset. This test is also authorized for non-prescription home use with adult-collected anterior nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first six days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests.

    * This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

    Partners of:

    • San Diego Padres logo
      San Diego Padres
    • San Diego Loyal logo
      San Diego Loyal
    • Chicago Blackhawks logo
      Chicago Blackhawks
    • New York Jets logo
      New York Jets
    • Los Angeles Rams logo
      Los Angeles Rams